SI1638539T1 - FARMACEVTSKI SESTAVKI, KI VSEBUJEJO pH OBÄŚUTLJIVE BLOK KOPOLIMERE IN HIDROFOBNO ZDRAVILNO UÄŚINKOVINO - Google Patents
FARMACEVTSKI SESTAVKI, KI VSEBUJEJO pH OBÄŚUTLJIVE BLOK KOPOLIMERE IN HIDROFOBNO ZDRAVILNO UÄŚINKOVINOInfo
- Publication number
- SI1638539T1 SI1638539T1 SI200431088T SI200431088T SI1638539T1 SI 1638539 T1 SI1638539 T1 SI 1638539T1 SI 200431088 T SI200431088 T SI 200431088T SI 200431088 T SI200431088 T SI 200431088T SI 1638539 T1 SI1638539 T1 SI 1638539T1
- Authority
- SI
- Slovenia
- Prior art keywords
- pharmaceutical compositions
- block copolymers
- poly
- alkyl
- hydrophobic drug
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- 229920001400 block copolymer Polymers 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 230000002209 hydrophobic effect Effects 0.000 title abstract 2
- 230000000712 assembly Effects 0.000 abstract 2
- 238000000429 assembly Methods 0.000 abstract 2
- 239000000693 micelle Substances 0.000 abstract 2
- -1 poly(ethylene oxide) Polymers 0.000 abstract 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 abstract 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 abstract 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 150000001768 cations Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000007613 environmental effect Effects 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
- C08L71/02—Polyalkylene oxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Polymers & Plastics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/607,446 US7094810B2 (en) | 2001-06-08 | 2003-06-25 | pH-sensitive block copolymers for pharmaceutical compositions |
| PCT/CA2004/000561 WO2004112757A1 (en) | 2003-06-25 | 2004-04-14 | Pharmaceutical compositions comprising ph-sensitive block copolymers and a hydrophobic drug |
| EP04727195A EP1638539B1 (en) | 2003-06-25 | 2004-04-14 | Pharmaceutical compositions comprising ph-sensitive block copolymers and a hydrophobic drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1638539T1 true SI1638539T1 (sl) | 2009-10-31 |
Family
ID=33540273
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200431088T SI1638539T1 (sl) | 2003-06-25 | 2004-04-14 | FARMACEVTSKI SESTAVKI, KI VSEBUJEJO pH OBÄŚUTLJIVE BLOK KOPOLIMERE IN HIDROFOBNO ZDRAVILNO UÄŚINKOVINO |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7094810B2 (sl) |
| EP (1) | EP1638539B1 (sl) |
| JP (1) | JP4619357B2 (sl) |
| AT (1) | ATE418970T1 (sl) |
| AU (1) | AU2004248863B2 (sl) |
| BR (1) | BRPI0411872A (sl) |
| CA (1) | CA2530736C (sl) |
| CY (1) | CY1110264T1 (sl) |
| DE (1) | DE602004018772D1 (sl) |
| DK (1) | DK1638539T3 (sl) |
| ES (1) | ES2323701T3 (sl) |
| MX (1) | MXPA05014017A (sl) |
| PL (1) | PL1638539T3 (sl) |
| PT (1) | PT1638539E (sl) |
| SI (1) | SI1638539T1 (sl) |
| WO (1) | WO2004112757A1 (sl) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003523544A (ja) * | 2000-02-17 | 2003-08-05 | レックスマーク・インターナショナル・インコーポレーテツド | 導電性駆動ハブを備えたトナーカートリッジ |
| US6939564B2 (en) * | 2001-06-08 | 2005-09-06 | Labopharm, Inc. | Water-soluble stabilized self-assembled polyelectrolytes |
| WO2005079856A1 (en) * | 2004-02-23 | 2005-09-01 | The University Of British Columbia | Drug delivery compositions comprising hydrophobic polymers and amphipathic molecules |
| US20060198891A1 (en) | 2004-11-29 | 2006-09-07 | Francois Ravenelle | Solid formulations of liquid biologically active agents |
| US20090074872A1 (en) * | 2006-06-26 | 2009-03-19 | Mutual Pharmaceutical Company, Inc. | Active Agent Formulations, Methods of Making, and Methods of Use |
| CA2656277A1 (en) * | 2006-06-26 | 2008-01-03 | Mutual Pharmaceutical Company, Inc. | Active agent formulations, methods of making, and methods of use |
| JP2010504318A (ja) * | 2006-09-22 | 2010-02-12 | ラボファーム インコーポレイテッド | ｐＨ標的化薬剤送達のための組成物及び方法 |
| WO2008079677A2 (en) * | 2006-12-20 | 2008-07-03 | Arkema Inc. | Polymer encapsulation and/or binding |
| AU2008241367A1 (en) * | 2007-04-20 | 2008-10-30 | University Of South Australia | Nanoparticle-coated capsule formulation for dermal drug delivery |
| EP2207570A2 (en) * | 2007-09-14 | 2010-07-21 | Nitto Denko Corporation | Drug carriers |
| FR2922452B1 (fr) * | 2007-10-19 | 2010-01-22 | Coatex Sas | Formulations de composes organoplatiniques en presence de polymeres associatifs, produits obtenus et leurs utilisations |
| TWI388591B (zh) * | 2008-03-28 | 2013-03-11 | Ind Tech Res Inst | 溫度敏感性材料 |
| US8778400B2 (en) * | 2008-04-21 | 2014-07-15 | University Of South Australia | Nanoparticle-stabilized capsule formulation for treatment of inflammation |
| MX2010012239A (es) * | 2008-05-13 | 2011-05-24 | Univ Washington | Montajes micelares. |
| MX2010012237A (es) * | 2008-05-13 | 2011-04-28 | Univ Washington | Micelas para el suministro intracelular de agentes terapeuticos. |
| AU2009246321A1 (en) * | 2008-05-13 | 2009-11-19 | Phaserx, Inc. | Polymeric carrier |
| WO2009140423A2 (en) * | 2008-05-13 | 2009-11-19 | University Of Washington | Targeted polymer bioconjugates |
| EP2620161A1 (en) | 2008-05-13 | 2013-07-31 | University of Washington | Diblock copolymers and polynucleotide complexes thereof for delivery into cells |
| KR101638201B1 (ko) * | 2008-05-16 | 2016-07-08 | 유니버시티 오브 시드니 | 투여 가능한 조성물 |
| CA2635187A1 (en) | 2008-06-05 | 2009-12-05 | The Royal Institution For The Advancement Of Learning/Mcgill University | Oligonucleotide duplexes and uses thereof |
| EP2305275B1 (en) * | 2008-06-24 | 2013-07-10 | NanoCarrier Co., Ltd. | Liquid composition comprising cisplatin-coordinating compound |
| CA2734917A1 (en) | 2008-08-22 | 2010-02-25 | University Of Washington | Heterogeneous polymeric micelles for intracellular delivery |
| WO2010053596A1 (en) | 2008-11-06 | 2010-05-14 | University Of Washington | Bispecific intracellular delivery vehicles |
| KR20110095292A (ko) | 2008-11-06 | 2011-08-24 | 유니버시티 오브 워싱톤 | 다중블록 공중합체 |
| JP2012511053A (ja) | 2008-12-08 | 2012-05-17 | ユニヴァーシティ オブ ワシントン | オメガ機能性化ポリマー、ジャンクション機能性化ブロック共重合体、およびラジカル連鎖延長重合 |
| US20100159010A1 (en) * | 2008-12-24 | 2010-06-24 | Mutual Pharmaceutical Company, Inc. | Active Agent Formulations, Methods of Making, and Methods of Use |
| TWI374903B (en) * | 2008-12-31 | 2012-10-21 | Ind Tech Res Inst | Biodegradable copolymer hydrogel materials |
| US9415113B2 (en) | 2009-11-18 | 2016-08-16 | University Of Washington | Targeting monomers and polymers having targeting blocks |
| CA3160394C (en) | 2013-07-30 | 2023-11-07 | Genevant Sciences Gmbh | Block copolymers and their conjugates or complexes with oligonucleotides |
| CN107530436B (zh) | 2015-01-21 | 2022-03-29 | 菲泽尔克斯公司 | 用于将治疗剂和诊断剂递送到细胞中的方法、组合物和系统 |
| JP2019510085A (ja) | 2016-03-08 | 2019-04-11 | ロス ガトス ファーマスーティカルズ， インク．Ｌｏｓ Ｇａｔｏｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 癌治療のためのナノ粒子ならびに方法および化合物 |
| EP3426352A4 (en) | 2016-03-08 | 2019-11-13 | Los Gatos Pharmaceuticals, Inc. | CAMPTOTHECIN DERIVATIVES AND USES THEREOF |
| CN106432647B (zh) * | 2016-09-26 | 2018-10-30 | 华南理工大学 | 基于叔氨基的pH响应嵌段聚合物及其混合胶束与应用 |
| EP3562510A4 (en) | 2016-12-30 | 2021-01-06 | Genevant Sciences GmbH | BRANCHED PEG MOLECULES AND ASSOCIATED COMPOSITIONS AND PROCEDURES |
| WO2019032975A1 (en) * | 2017-08-10 | 2019-02-14 | Mec Device Pharma International Llc | ANTI-ABUSE MEDICINAL FORMULATIONS |
| CN114377144A (zh) * | 2022-01-28 | 2022-04-22 | 南通大学 | pH/活性氧双重响应性超分子聚肽前药纳米粒子 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1411843A (en) * | 1973-02-28 | 1975-10-29 | Univ Strathclyde | Method of modifying the properties of a polymer |
| JPS5767860A (en) * | 1980-10-15 | 1982-04-24 | Fuji Photo Film Co Ltd | Material for multilayer analysis |
| JP2517760B2 (ja) | 1989-05-11 | 1996-07-24 | 新技術事業団 | 水溶性高分子化医薬製剤 |
| KR940003548U (ko) | 1992-08-14 | 1994-02-21 | 김형술 | 세탁물 건조기 |
| US5840319A (en) | 1992-10-08 | 1998-11-24 | Alakhov; Valery Yu | Biological agent compositions |
| EP0639592A1 (en) * | 1993-08-18 | 1995-02-22 | Nippon Shokubai Co., Ltd. | Water-soluble graft polymers and production process thereof |
| US5786387A (en) | 1994-03-23 | 1998-07-28 | Meiji Seika Kabushiki Kaisha | Lipid double-chain derivative containing polyoxyethylene |
| US5620850A (en) | 1994-09-26 | 1997-04-15 | President And Fellows Of Harvard College | Molecular recognition at surfaces derivatized with self-assembled monolayers |
| US5997861A (en) | 1994-10-31 | 1999-12-07 | Burstein Laboratories, Inc. | Antiviral supramolecules containing target-binding molecules and therapeutic molecules bound to spectrin |
| US5656611A (en) | 1994-11-18 | 1997-08-12 | Supratek Pharma Inc. | Polynucleotide compositions |
| US6221959B1 (en) | 1994-11-18 | 2001-04-24 | Supratek Pharma, Inc. | Polynucleotide compositions |
| AU4690596A (en) | 1994-12-30 | 1996-07-24 | Chiron Viagene, Inc. | Nucleic acid condensing agents with reduced immunogenicity |
| US5492996A (en) * | 1995-02-21 | 1996-02-20 | The United States Of America As Represented By The Secretary Of The Air Force | Alcohol soluble benzazole polymers |
| RU2169742C2 (ru) | 1995-04-19 | 2001-06-27 | Катаока Казунори | Гетеротелехелатный блок-сополимер и способ его получения |
| US5908777A (en) | 1995-06-23 | 1999-06-01 | University Of Pittsburgh | Lipidic vector for nucleic acid delivery |
| NZ313769A (en) | 1995-08-10 | 2000-02-28 | Kazunori Kataoka | block polymer having a functional group presented on each end |
| US5770627A (en) | 1995-08-16 | 1998-06-23 | University Of Washington | Hydrophobically-modified bioadhesive polyelectrolytes and methods relating thereto |
| US5702717A (en) | 1995-10-25 | 1997-12-30 | Macromed, Inc. | Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers |
| DE69707853T2 (de) | 1996-03-15 | 2002-06-27 | Harvard College | Verfahren zum formen von gegenständen und zum mikrostrukturieren von oberflächen durch giessformen mit kapillarwirkung |
| US5955509A (en) | 1996-05-01 | 1999-09-21 | Board Of Regents, The University Of Texas System | pH dependent polymer micelles |
| JP2001508762A (ja) * | 1996-06-27 | 2001-07-03 | ジー．ディー．サール アンド カンパニー | 架橋した外殻領域および内部芯領域を有する両親媒性コポリマーからなり、医薬およびその他の用途に有用な粒子 |
| GB9623051D0 (en) | 1996-11-06 | 1997-01-08 | Schacht Etienne H | Delivery of DNA to target cells in biological systems |
| EP1019064A4 (en) | 1997-02-28 | 2006-11-08 | Univ California | INHIBITION OF CELL-CELL BINDINGS BY LIPID COMPOSITIONS |
| EP0963758A3 (en) | 1998-05-07 | 2000-03-22 | Universiteit Gent | Synthetic polyaminoacid complexes for delivery of nucleic acids to target cells |
| US5939453A (en) | 1998-06-04 | 1999-08-17 | Advanced Polymer Systems, Inc. | PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers |
| JP2002520435A (ja) | 1998-07-13 | 2002-07-09 | エクスプレション・ジェネティックス・インコーポレーテッド | 可溶性、生物分解性な遺伝子輸送キャリアーとしてのポリ−ｌ−リジンのポリエステル類似体 |
| DE19919785A1 (de) | 1999-04-30 | 2000-12-07 | Wella Ag | Haarbehandlungsmittel mit Polymeren aus ungesättigten Sacchariden, ungesättigten Saccharidsäuren oder deren Derivaten |
| DE10008895A1 (de) | 2000-02-25 | 2001-08-30 | Beiersdorf Ag | Stabilisierung oxidations- und/oder UV-empfindlicher Wirkstoffe |
| AU2001276627A1 (en) | 2000-05-17 | 2001-11-26 | Labopharm Inc. | Drug containing polymeric micelles |
| US6939564B2 (en) * | 2001-06-08 | 2005-09-06 | Labopharm, Inc. | Water-soluble stabilized self-assembled polyelectrolytes |
| US6780428B2 (en) | 2001-06-08 | 2004-08-24 | Labopharm, Inc. | Unimolecular polymeric micelles with an ionizable inner core |
| GB0131112D0 (en) * | 2001-12-31 | 2002-02-13 | Univ London Pharmacy | Block copolymers |
| JP4266926B2 (ja) | 2002-10-21 | 2009-05-27 | ロレアル | 両親媒性ブロックコポリマーを用いた水溶液に脂質親和性化合物を溶解させる方法、及び化粧品用組成物 |
-
2003
- 2003-06-25 US US10/607,446 patent/US7094810B2/en not_active Expired - Lifetime
-
2004
- 2004-04-14 PT PT04727195T patent/PT1638539E/pt unknown
- 2004-04-14 DE DE602004018772T patent/DE602004018772D1/de not_active Expired - Lifetime
- 2004-04-14 AU AU2004248863A patent/AU2004248863B2/en not_active Ceased
- 2004-04-14 JP JP2006515571A patent/JP4619357B2/ja not_active Expired - Lifetime
- 2004-04-14 WO PCT/CA2004/000561 patent/WO2004112757A1/en active Application Filing
- 2004-04-14 ES ES04727195T patent/ES2323701T3/es not_active Expired - Lifetime
- 2004-04-14 MX MXPA05014017A patent/MXPA05014017A/es active IP Right Grant
- 2004-04-14 BR BRPI0411872-3A patent/BRPI0411872A/pt not_active IP Right Cessation
- 2004-04-14 EP EP04727195A patent/EP1638539B1/en not_active Expired - Lifetime
- 2004-04-14 PL PL04727195T patent/PL1638539T3/pl unknown
- 2004-04-14 SI SI200431088T patent/SI1638539T1/sl unknown
- 2004-04-14 CA CA2530736A patent/CA2530736C/en not_active Expired - Lifetime
- 2004-04-14 DK DK04727195T patent/DK1638539T3/da active
- 2004-04-14 AT AT04727195T patent/ATE418970T1/de active
-
2009
- 2009-03-31 CY CY20091100371T patent/CY1110264T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004112757A1 (en) | 2004-12-29 |
| PL1638539T3 (pl) | 2009-10-30 |
| JP2007505029A (ja) | 2007-03-08 |
| JP4619357B2 (ja) | 2011-01-26 |
| DK1638539T3 (da) | 2009-05-04 |
| US20040072784A1 (en) | 2004-04-15 |
| ES2323701T3 (es) | 2009-07-23 |
| CY1110264T1 (el) | 2015-01-14 |
| PT1638539E (pt) | 2009-04-09 |
| AU2004248863A1 (en) | 2004-12-29 |
| EP1638539B1 (en) | 2008-12-31 |
| DE602004018772D1 (de) | 2009-02-12 |
| CA2530736C (en) | 2013-07-02 |
| AU2004248863B2 (en) | 2009-03-12 |
| CA2530736A1 (en) | 2004-12-29 |
| US7094810B2 (en) | 2006-08-22 |
| EP1638539A1 (en) | 2006-03-29 |
| BRPI0411872A (pt) | 2006-08-08 |
| MXPA05014017A (es) | 2007-01-31 |
| ATE418970T1 (de) | 2009-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1638539T1 (sl) | FARMACEVTSKI SESTAVKI, KI VSEBUJEJO pH OBÄŚUTLJIVE BLOK KOPOLIMERE IN HIDROFOBNO ZDRAVILNO UÄŚINKOVINO | |
| WO2003044076A8 (en) | Bioerodible poly(ortho esters) containing amine groups, and block copolymers containing them | |
| CA2462606A1 (en) | Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer | |
| DE60044459D1 (de) | IN ORGANISCHEN LÖSEMITTELN LÖSLICHE BIOLOGISCH ABBAUBARE POLY (ALKYLENOXID)- POLY (p-DIOXANON) BLOCKCOPOLYMERE SOWIE DIESE ENTHALTENDE ZUSAMMENSETZUNG ZUR ARZNEISTOFFVERABREICHUNG | |
| ATE313586T1 (de) | Mehrarmige blockcopolymere und pharmazeutische zusammensetzung | |
| CA2430481A1 (en) | Compositions for sustained delivery of hydrophobic drugs and process for the preparation thereof | |
| CA2483282A1 (en) | Polymeric microemulsions | |
| CA2408716A1 (en) | Stable polymeric micelle-type drug composition and method for the preparation thereof | |
| BR0111016A (pt) | Composições farmacêuticas de liberação sustentada para a administração parenteral de compostos hidrófilos biologicamente ativos | |
| CA2329005A1 (en) | Folic acid-containing pharmaceutical compositions, and related methods and delivery systems | |
| ATE363898T1 (de) | Mizellares arzneistoffverabreichungssystem für hydrophobe arzneistoffe | |
| WO2005072343A3 (en) | Aqueous pharmaceutical compositions 2,6-diisopropylphenol (propofol) and their use | |
| HUP0400264A2 (hu) | Alacsony oldékonyságú és/vagy savra érzékeny hatóanyagokat és semlegesített savas polimereket tartalmazó gyógyszerkészítmények és eljárás az előállításukra | |
| ATE424848T1 (de) | Pharmazeutische zusammensetzungen für die kontrollierte freigabe von biologischen wirkstoffen | |
| ATE396967T1 (de) | (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten | |
| ATE427760T1 (de) | Erodierbare polymere zur injektion | |
| DE60216305D1 (de) | Zusammensetzungen zur verabreichung von arzneimittelkombinationen | |
| BR0213379A (pt) | Formulação resistente a derramamento de mascaramento de gosto | |
| EP1569664A4 (en) | BIOERODABLE POLY (ORTHO ESTERS) PREPARED FROM DI (CETENE ACETALS) BASED ON DIOXANE AND COPOLYMER SEQUENCES CONTAINING THE SAME | |
| EP1499359A1 (en) | Temperature responsive delivery systems | |
| CA2390029A1 (en) | Suspension comprising oxcarbazepine | |
| HRP20090022T3 (en) | Pharmaceutical compositions comprising ascorbic acid for the treatment of fungal superfinfections and fungal recurrences | |
| CA2238521A1 (en) | Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial | |
| WO2004078111A3 (en) | Extended release minocycline compositions and processes for their preparation | |
| CA2455710A1 (en) | Calcium salts with cytotoxic activity |